Abstract

Knowledge about anatomical details seems to facilitate the procedure and planning of prostatic artery embolization (PAE) in patients with symptomatic benign prostatic hyperplasia (BPS). The aim of our study was the pre-interventional visualization of the prostatic artery (PA) with MRA and the correlation of iliac elongation and bifurcation angles with technical success of PAE and technical parameters. MRA data of patients with PAE were analysed retrospectively regarding PA visibility, PA type, vessel elongation, and defined angles were correlated with intervention time, fluoroscopy time, dose area product (DAP), cumulative air kerma (CAK), contrast media (CM) dose and technical success of embolization. T-test, ANOVA, Pearson correlation, and Kruskal–Wallis test was applied for statistical analysis. Between April 2018 and March 2021, a total of 78 patients were included. MRA identified the PA origin in 126 of 147 cases (accuracy 86%). Vessel elongation affected time for catheterization of right PA (p = 0.02), fluoroscopy time (p = 0.05), and CM dose (p = 0.02) significantly. Moderate correlation was observed for iliac bifurcation angles with DAP (r = 0.30 left; r = 0.34 right; p = 0.01) and CAK (r = 0.32 left; r = 0.36 right; p = 0.01) on both sides. Comparing the first half and second half of patients, median intervention time (125 vs. 105 min.) and number of iliac CBCT could be reduced (p < 0.001). We conclude that MRA could depict exact pelvic artery configuration, identify PA origin, and might obviate iliac CBCT. Vessel elongation of pelvic arteries increased intervention time and contrast media dose while the PA origin had no significant influence on intervention time and/or technical success.

Details

Title
Value of magnetic resonance angiography before prostatic artery embolization for intervention planning
Author
Boschheidgen, Matthias 1 ; Ullrich, Tim 1 ; Al-Monajjed, Rouvier 2 ; Ziayee, Farid 1 ; Michalski, Rene 2 ; Steuwe, Andrea 1 ; Minko, Peter 1 ; Albers, Peter 2 ; Antoch, Gerald 1 ; Schimmöller, Lars 3   VIAFID ORCID Logo 

 University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917) 
 University Dusseldorf, Medical Faculty, Department of Urology, Dusseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917) 
 University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917); University Hospital of the Ruhr-University Bochum, Department of Diagnostic, Interventional Radiology and Nuclear Medicine, Marien Hospital Herne, Herne, Germany (GRID:grid.5570.7) (ISNI:0000 0004 0490 981X) 
Pages
7758
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3030940232
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.